Dendritic Cell-Based Immunotherapy for Prostate Cancer

Dendritic cells (DCs) are professional antigen-presenting cells (APCs), which display an extraordinary capacity to induce, sustain, and regulate T-cell responses providing the opportunity of DC-based cancer vaccination strategies. Thus, clinical trials enrolling prostate cancer patients were conduct...

Full description

Bibliographic Details
Published in:	Clinical and Developmental Immunology
Main Authors:	Hanka Jähnisch, Susanne Füssel, Andrea Kiessling, Rebekka Wehner, Stefan Zastrow, Michael Bachmann, Ernst Peter Rieber, Manfred P. Wirth, Marc Schmitz
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Online Access:	http://dx.doi.org/10.1155/2010/517493

Similar Items

Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells
by: Rebekka Wehner, et al.
Published: (2009-08-01)

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
by: Kai Naumann, et al.
Published: (2013-01-01)

Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients
by: Johanna Kirchner, et al.
Published: (2024-06-01)

Advances in renal cell carcinoma treatment
by: Marc-Oliver Grimm, et al.
Published: (2010-02-01)

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment
by: Antje Tunger, et al.
Published: (2018-03-01)

Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial
by: Unger C, et al.
Published: (2004-07-01)

Proinflammatory human 6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease
by: Ulrich Sommer, et al.
Published: (2014-06-01)

Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer
by: Felix Wagner, et al.
Published: (2019-03-01)

Dendritic cell subsets and implications for cancer immunotherapy
by: Michael Y. Chen, et al.
Published: (2024-06-01)

Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration
by: Min-Seon Song, et al.
Published: (2024-01-01)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
by: Chunmei Fu, et al.
Published: (2022-01-01)

Effects of Injectable Solutions on the Quality of Monocyte-Derived Dendritic Cells for Immunotherapy
by: Laís Teodoro Da Silva, et al.
Published: (2024-01-01)

Cytokine-overexpressing dendritic cells for cancer immunotherapy
by: Joonsu Han, et al.
Published: (2024-12-01)

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
by: Jie Chen, et al.
Published: (2024-09-01)

DNA sensing of dendritic cells in cancer immunotherapy
by: Wei Qian, et al.
Published: (2024-05-01)

Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
by: Shumin Luo, et al.
Published: (2023-08-01)

Regulatory dendritic cells for immunotherapy in immunologic diseases
by: John Robert Gordon, et al.
Published: (2014-01-01)

Dendritic cell-based immunotherapy for myeloid leukemias
by: Christian Martijn Schürch, et al.
Published: (2013-12-01)

Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment
by: Emily L. Hopewell, et al.
Published: (2020-03-01)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
by: Raquel S Laureano, et al.
Published: (2022-12-01)

Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation
by: Kati Erdmann, et al.
Published: (2017-06-01)

Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells
by: Oscar Badillo, et al.
Published: (2024-04-01)

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
by: João Calmeiro, et al.
Published: (2020-02-01)

IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT
by: A. S. Ilnitskaya, et al.
Published: (2018-07-01)

Liposomal Dendritic Cell Vaccine in Breast Cancer Immunotherapy
by: Hong Pan, et al.
Published: (2021-01-01)

Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
by: Heng Dong, et al.
Published: (2023-06-01)

Multi-compartment immune cell profiling highlights the prognostic relevance of CD127+ CD8+ T cells for patients with high-grade serous ovarian cancer
by: Rebecca Rothe, et al.
Published: (2025-10-01)

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation
by: Simone P. Sittig, et al.
Published: (2015-12-01)

Dendritic Cell-Derived Exosomes: Next Generation of Cancer Immunotherapy
by: Rajib Dhar, et al.
Published: (2025-10-01)

Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy
by: Valerie R. Yanofsky, et al.
Published: (2013-01-01)

Optimal Control of Tumor Growth Model with Dendritic Cells as Immunotherapy
by: Firmansyah Reskal Motulo, et al.
Published: (2018-06-01)

Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
by: Jiřina Bartůňková
Published: (2024-03-01)

Dendritic Cell as Potential Immunotherapy for Nasopharyngeal Cancer: A Review
by: Albertus Budi Sulistya, et al.
Published: (2023-10-01)

The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy
by: Ribeiro AR, et al.
Published: (2024-10-01)

In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy
by: Joonsu Han, et al.
Published: (2022-08-01)

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
by: Mandy van Gulijk, et al.
Published: (2018-12-01)

Immunotherapy in metastatic prostate cancer
by: Liam Dwyer, et al.
Published: (2025-06-01)

Immunotherapy in metastatic prostate cancer
by: Susan F Slovin
Published: (2016-01-01)

Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer
by: Carolin Schimmelpfennig, et al.
Published: (2023-06-01)

Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer
by: Angelika Borkowetz, et al.
Published: (2020-08-01)